Integrating Current Evidence and Individualized Treatment Regimens Into Clinical Practice for Patients With Myeloproliferative Neoplasms

Download All
Gain expert insights on the latest evidence-based strategies and emerging therapies for the management of essential thrombocythemia, polycythemia vera, and myelofibrosis with a comprehensive educational program featuring an Interactive Decision Support Tool, on-demand podcasts, and commentaries.
Raajit Rampal, MD, PhD
Brady L. Stein, MD, MHS
Prithviraj Bose, MD
person default
John Mascarenhas, MD
person default
Ruben A. Mesa, MD, FACP
Raajit Rampal, MD, PhD
Brady L. Stein, MD, MHS

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choices of therapy for patients with myelofibrosis with those of 5 renowned experts.

Prithviraj Bose, MD person default John Mascarenhas, MD person default Ruben A. Mesa, MD, FACP Raajit Rampal, MD, PhD Brady L. Stein, MD, MHS Released: May 8, 2023

Podcasts

Listen as experts discuss how they tailor current therapeutic options for different patients with polycythemia vera.

Raajit Rampal, MD, PhD Brady L. Stein, MD, MHS Released: January 11, 2023
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
GSK
Incyte Corporation
PharmaEssentia Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings